These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2680192)

  • 1. Interleukin 1-induced pathophysiology: induction of cytokines, development of histopathologic changes, and immunopharmacologic intervention.
    Butler LD; Layman NK; Cain RL; Riedl PE; Mohler KM; Bobbitt JL; Belagajie R; Sharp J; Bendele AM
    Clin Immunol Immunopathol; 1989 Dec; 53(3):400-21. PubMed ID: 2680192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Temporal sequence of pulmonary cytokine gene expression in response to endotoxin in C3H/HeN endotoxin-sensitive and C3H/HeJ endotoxin-resistant mice.
    Nill MR; Oberyszyn TM; Ross MS; Oberyszyn AS; Robertson FM
    J Leukoc Biol; 1995 Nov; 58(5):563-74. PubMed ID: 7595058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adrenalectomy sensitizes mice to the lethal effects of interleukin 1 and tumor necrosis factor.
    Bertini R; Bianchi M; Ghezzi P
    J Exp Med; 1988 May; 167(5):1708-12. PubMed ID: 3259257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-1 induces a shock-like state in rabbits: synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition.
    Dinarello CA; Okusawa S; Gelfand JA
    Prog Clin Biol Res; 1989; 286():243-63. PubMed ID: 2494673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pretreatment with recombinant murine tumor necrosis factor alpha/cachectin and murine interleukin 1 alpha protects mice from lethal bacterial infection.
    Cross AS; Sadoff JC; Kelly N; Bernton E; Gemski P
    J Exp Med; 1989 Jun; 169(6):2021-7. PubMed ID: 2659724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interdependence of the radioprotective effects of human recombinant interleukin 1 alpha, tumor necrosis factor alpha, granulocyte colony-stimulating factor, and murine recombinant granulocyte-macrophage colony-stimulating factor.
    Neta R; Oppenheim JJ; Douches SD
    J Immunol; 1988 Jan; 140(1):108-11. PubMed ID: 2447166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The glucocorticoid antagonist RU38486 mimics interleukin-1 in its sensitization to the lethal and interleukin-6-inducing properties of tumor necrosis factor.
    Brouckaert P; Everaerdt B; Fiers W
    Eur J Immunol; 1992 Apr; 22(4):981-6. PubMed ID: 1532365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased resistance of LFA-1-deficient mice to lipopolysaccharide-induced shock/liver injury in the presence of TNF-alpha and IL-12 is mediated by IL-10: a novel role for LFA-1 in the regulation of the proinflammatory and anti-inflammatory cytokine balance.
    Emoto M; Emoto Y; Brinkmann V; Miyamoto M; Yoshizawa I; Stäber M; van Rooijen N; Hamann A; Kaufmann SH
    J Immunol; 2003 Jul; 171(2):584-93. PubMed ID: 12847222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endotoxin, tumor necrosis factor-alpha and interleukin 1 induce interleukin 6 production in vivo.
    Shalaby MR; Waage A; Aarden L; Espevik T
    Clin Immunol Immunopathol; 1989 Dec; 53(3):488-98. PubMed ID: 2805453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor necrosis factor and interleukin 1 as mediators of endotoxin-induced beneficial effects.
    Urbaschek R; Urbaschek B
    Rev Infect Dis; 1987; 9 Suppl 5():S607-15. PubMed ID: 3317753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetics and mechanisms of recombinant human interleukin 1 and tumor necrosis factor-alpha-induced changes in circulating numbers of neutrophils and lymphocytes.
    Ulich TR; del Castillo J; Keys M; Granger GA; Ni RX
    J Immunol; 1987 Nov; 139(10):3406-15. PubMed ID: 3316383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of post-treatment with low-dose propofol on inflammatory responses to lipopolysaccharide-induced shock in conscious rats.
    Hsu BG; Yang FL; Lee RP; Peng TC; Chen HI
    Clin Exp Pharmacol Physiol; 2005; 32(1-2):24-9. PubMed ID: 15730430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Western blot analysis of bile or intestinal fluid from patients with septic shock or systemic inflammatory response syndrome, using antibodies to TNF-alpha, IL-1 alpha and IL-1 beta.
    Belov L; Meher-Homji V; Putaswamy V; Miller R
    Immunol Cell Biol; 1999 Feb; 77(1):34-40. PubMed ID: 10101684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroendocrine regulation of in vivo cytokine production and effects: I. In vivo regulatory networks involving the neuroendocrine system, interleukin-1 and tumor necrosis factor-alpha.
    Butler LD; Layman NK; Riedl PE; Cain RL; Shellhaas J; Evans GF; Zuckerman SH
    J Neuroimmunol; 1989 Sep; 24(1-2):143-53. PubMed ID: 2681261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioassay for interleukin-1, interleukin-6, and tumor necrosis factor-like activities in canine sera.
    Yamashita K; Fujinaga T; Hagio M; Miyamoto T; Izumisawa Y; Kotani T
    J Vet Med Sci; 1994 Feb; 56(1):103-7. PubMed ID: 8204733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipopolysaccharide-induced down-regulation of organic anion transporting polypeptide 4 (Oatp4; Slc21a10) is independent of tumor necrosis factor-alpha, Interleukin-1beta, interleukin-6, or inducible nitric oxide synthase.
    Li N; Klaassen CD
    Toxicol Sci; 2005 Jan; 83(1):197-203. PubMed ID: 15483191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-2 induced systemic toxicity: induction of mediators and immunopharmacologic intervention.
    Butler LD; Mohler KM; Layman NK; Cain RL; Riedl PE; Puckett LD; Bendele AM
    Immunopharmacol Immunotoxicol; 1989; 11(2-3):445-87. PubMed ID: 2695567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Negative regulators of in vivo erythropoiesis: interaction of IL-1 alpha and TNF-alpha and the lack of a strict requirement for T or NK cells for their activity.
    Johnson CS; Pourbohloul SC; Furmanski P
    Exp Hematol; 1991 Feb; 19(2):101-5. PubMed ID: 1991491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection, characterisation and purification of a murine liver factor capable of desensitising towards the lethal activity of tumour necrosis factor.
    Wielockx B; Hochepied T; Staelens J; Van Molle W; Brouckaert P; Libert C
    Cytokine; 2001 Jul; 15(2):59-65. PubMed ID: 11500080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-1, -6 and tumor necrosis factor-alpha release is down-regulated in whole blood from septic patients.
    Kremer JP; Jarrar D; Steckholzer U; Ertel W
    Acta Haematol; 1996; 95(3-4):268-73. PubMed ID: 8677754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.